期刊文献+

MELD与改良MELD在评价慢性重型肝炎预后中的应用与比较 被引量:1

A comparative study of five prognostic systems for predicting the prognosis of patients with chronic severe hepatitis
下载PDF
导出
摘要 目的比较终末期肝病模型(MELD)及改良MELD评分系统预测慢性重型肝炎患者预后的价值。方法回顾性分析76例慢性重型肝炎患者的临床资料,计算患者入院时的MELD评分、MESO指数、MELD-Na、iMELD和uMELD评分值,所有患者随访3月,绘制受试者工作特征曲线并计算曲线下面积(AUC),应用正态Z检验对曲线下面积进行比较。结果 76例慢性重型肝炎随访3月后死亡56例,生存20例,死亡组患者MELD评分、MESO指数、MELD-Na、iMELD和uMELD评分值均高于生存组,差异具有统计学意义(P<0.01)。各评分系统的AUC分别为0.786、0.788、0.749、0.862、0.768,差异无统计学意义。结论 MELD评分、MESO指数、MELD-Na、iMELD和uMELD评分对评价慢性重型肝炎预后均有较好的价值。 Objective To compare the predictive values of five prognostic system including model for end stage liver disease(MELD),MELD-Na,MESO,integrated MELD(iMELD),updated MELD(uMELD) in predicting the prognosis of patients with chronic severe hepatitis. Methods 76 patients with chronic severe hepatitis were retrospectively studied and followed-up for 3 months.MELD,MELD-Na,MESO,iMELD and uMELD scores were caculated at the day of admission. Area under the curve(AUC) was calculated and compared by Z-test. Results Of 76 patients,there were56 cases dead and 20 survived. The scores in dead group evaluated by MELD,MELD-Na,MESO,iMELD and uMELD scoring systems were higher than those in survival group(P〈0. 01). The values of AUC of these five system were 0. 786,0. 788,0. 749,0. 862 and 0. 768 respectively. Conclusion MELD,MELD-Na,MESO,iMELD and uMELD are all useful prognostic indicator for patients with chronic severe hepatitis.
出处 《实用临床医药杂志》 CAS 2014年第16期36-39,共4页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11321337)
关键词 慢性重型肝炎 预后 生存分析 危险性评估 终末期肝病模型 chronic severe hepatitis prognosis risk assessment end stage liver disease
  • 相关文献

参考文献4

二级参考文献16

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 2陶晨 汤小宁.慢性重型肝炎痊愈与死亡对比分析[J].临床医学,1999,4:18-19.
  • 3Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease.Hepatology,2001,33:464-470.
  • 4Ruf AE,Kremers WK,Chavez LL,et al.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.Liver Transp1,2005,11:336-343.
  • 5Luca A,Angermayr B,Bertolini G,et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cinhosis.Liver Transpl,2007,13:1174-1180.
  • 6Malinchoc M,Kamath PS,Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology,2000,31:864-871.
  • 7Biggins SW,Kim WR,Terrault NA,et al.Evidence-based incorporation of serum sodium concentration into MELD.Gastroenterology,2006,130:1652-1660.
  • 8Acharya SK,Dasarathy S,Kumer TL,etal. Fulminant hepatitis in a tropical population: clinical course,cause,and earlypredictors of outcome.Hepatology,1996,23:1448-1455.
  • 9Kondo M,Hada T,Fukui K,et al. Enzyme-linked immunosorbent assay(ELISA) for Aleuriaaurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronichepatitis. Clin Chim Acta,1995,243:1-9.
  • 10Huo TI,Wu JC,Sheng WY,et al.Prognostic factor analysis of fulminant andsubfulminant hepatic failure in an area endemic for hepatitis B.J GastroenterolHepatol,1996,11:560-565.

共引文献81

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部